Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

Development of Hypertension and Atrial Fibrillation Following Diagnosis of B-Cell Malignancies - a Retrospective Analysis of US Marketscan Insurance Claims Database

Lili Zhou, Binglin Yue, Soraya Azmi, Meng Zhang, Aileen Cleary Cohen

Blood (2022) 140 (Supplement 1): 12377–12378.

https://doi.org/10.1182/blood-2022-167596

Published: 2022

Journal Articles

Real-World Evidence (RWE) Studies Supported Hematologic Oncology United States Food and Drug Administration (US FDA) Approval: What Do They Look like?

Binglin Yue, Adam Greenbaum, Shaohui Sun, Enda Zhu, Shicheng Weng, Chenmu Du, Xiaojuan Zhang, Shanmei Liao

Blood (2022) 140 (Supplement 1): 13208–13209.

https://doi.org/10.1182/blood-2022-166800

Published: 2022

Journal Articles

Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation

Justina Ofori Frimpong, PharmD, BCOP, Rebecca Tombleson, PharmD, BCOP, Melissa Alsina, Jamie Shapiro, PharmD, BCOP, Jongphil Kim, PhD, Binglin Yue, MS, Janelle Perkins, PharmD, BCOP, Taiga Nishihori, MD

Blood (2016) 128 (22): 4636.

https://doi.org/10.1182/blood.V128.22.4636.4636

Published: 2016

Journal Articles

Body Composition Predicts Survival in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Asmita Mishra, MD, Binglin Yue, Martine Extermann, MD PhD, Claudio Anasetti, MD, Heather Jim, Jongphil Kim, Joseph A Pidala, MD, PhD, Vickie E Baracos

Blood (2015) 126 (23): 2113.

https://doi.org/10.1182/blood.V126.23.2113.2113

Published: 2015

Journal Articles

Hypo-Albuminemia at Day+90 after Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies Independently Predicts for Inferior Overall Survival and Higher Non-Relapse Mortality

Josephine Emole, MD, Mohamed A. Kharfan-Dabaja, MD, Julio C Chavez, MD, Taiga Nishihori, MD, Marcie Riches, MD, Asmita Mishra, MD, Binglin Yue, Jongphil Kim, Ernesto Ayala, MD, Claudio Anasetti, MD, Frederick L Locke, MD

Blood (2015) 126 (23): 4407.

https://doi.org/10.1182/blood.V126.23.4407.4407

Published: 2015

Journal Articles

Sirolimus, Tacrolimus and Antithymocyte Globulin Are Associated with Improved Overall Survival When Compared to Methotrexate, Tacrolimus and Antithymocyte Globulin in Mismatched Unrelated Allogeneic Hematopoietic Cell Transplantation

Rebecca Nelson, PharmD, Janelle Perkins, PharmD, Jamie Shapiro, PharmD, Jongphil Kim, PhD, Binglin Yue, M.S., Claudio Anasetti, MD, Mohamed A Kharfan-Dabaja, MD

Blood (2014) 124 (21): 2553.

https://doi.org/10.1182/blood.V124.21.2553.2553

Published: 2014

Journal Articles

A Strong Correlation Between Spot Urine Protein To Creatinine Ratio and 24-Hour Urine Protein Quantification For Proteinuria Assessment In Patients With Plasma Cell Dyscrasia

Apuri Susmitha, MD, Taiga Nishihori, MD, Karen Lin, MD, Rachid Baz, MD, Binglin Yue, MS, Jongphil Kim, PhD, Kenneth H. Shain, MD, PhD, Elias Doumit, MD, Jose L Ochoa-Bayona, MD, Daniel M Sullivan, MD, Melissa Alsina, MD, Benjamin Djulbegovic, MD, PhD

Blood (2013) 122 (21): 3155.

https://doi.org/10.1182/blood.V122.21.3155.3155

Published: 2013

Journal Articles

Th17 Lymphocytes In Human Gvhd Target Tissues Are Associated With Disease Severity and Refractoriness To Systemic Glucocorticoid Therapy

Joseph Pidala, MD, MS, Elizabeth M. Sagatys, MD, Mark Lloyd, MS, Jongphil Kim, PhD, Binglin Yue, MS, Brian C Betts, MD, Claudio Anasetti, MD

Blood (2013) 122 (21): 2054.

https://doi.org/10.1182/blood.V122.21.2054.2054

Published: 2013

Journal Articles

Updated Results of Phase II Study of Cyclophosphamide(Cy), Bortezomib(Bz), Pegylated Doxorubicin(DOX), and Dexamethasone(dex), (CVDD), in Patients with Newly Diagnosed Myeloma:an Effective Induction Regimen for High Risk Disease

Melissa Alsina, MD, Rachid Baz, MD, Kenneth H. Shain, MD, PhD, Leonel Ochoa, MD, Taiga Nishihori, MD, Daniel M Sullivan, MD, Binglin Yue, Jongphil Kim, PhD, William Dalton, PhD, MD

Blood (2012) 120 (21): 4071.

https://doi.org/10.1182/blood.V120.21.4071.4071

Published: 2012

NARROW

Development of Hypertension and Atrial Fibrillation Following Diagnosis of B-Cell Malignancies - a Retrospective Analysis of US Marketscan Insurance Claims Database

Real-World Evidence (RWE) Studies Supported Hematologic Oncology United States Food and Drug Administration (US FDA) Approval: What Do They Look like?

Impact of Obesity in Patients with Multiple Myeloma Receiving High-Dose Melphalan Followed By Autologous Hematopoietic Cell Transplantation

Body Composition Predicts Survival in Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Recipients

Hypo-Albuminemia at Day+90 after Allogeneic Hematopoietic Cell Transplantation for Lymphoid Malignancies Independently Predicts for Inferior Overall Survival and Higher Non-Relapse Mortality

Sirolimus, Tacrolimus and Antithymocyte Globulin Are Associated with Improved Overall Survival When Compared to Methotrexate, Tacrolimus and Antithymocyte Globulin in Mismatched Unrelated Allogeneic Hematopoietic Cell Transplantation

A Strong Correlation Between Spot Urine Protein To Creatinine Ratio and 24-Hour Urine Protein Quantification For Proteinuria Assessment In Patients With Plasma Cell Dyscrasia

Th17 Lymphocytes In Human Gvhd Target Tissues Are Associated With Disease Severity and Refractoriness To Systemic Glucocorticoid Therapy

Updated Results of Phase II Study of Cyclophosphamide(Cy), Bortezomib(Bz), Pegylated Doxorubicin(DOX), and Dexamethasone(dex), (CVDD), in Patients with Newly Diagnosed Myeloma:an Effective Induction Regimen for High Risk Disease

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only